<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150411021686N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-01</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of electrical stimulation of the brain with virtual reality on people with multiple sclerosis</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of transcranial direct current stimulation with virtual reality ‎training for balance and fear of falling in people with multiple sclerosis, a ‎randomized control trial ‎</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73826</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In the first stage, patients who meet the inclusion criteria are included in the study. Therefore, our sampling method is convenience sampling at this stage of the method. The randomization method in this research is a web-based block randomization, due to having three groups, blocks of 3 and 6 will be used, and the order of the blocks will be obtained using random numbers on the web, so it can be 36 The participant was randomly assigned to the study. Participants are placed in three control, sham and intervention groups based on the order of entry. The assessor will not know about the random allocation and group allocation of the participants in any of the assessment stages. The number of blocks and how they are executed is done by hiding them inside the envelope, Blinding description: A single-blind , the assessor will be blind to group allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>multiple sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: receiving virtual reality balance exercises with bright tDCS. To use tDCS, a direct stimulation current will be used by a pair of electrodes (cathode and anode). The current is controlled by an ammeter. Stimulation electrodes are 7x5 cm in size. When using TDCS, a current of 2 mA is applied to the cerebellum for a maximum of 20 minutes. Virtual reality device Visual cues are created by a virtual reality device. A closed loop device is installed on the head. , provides the patient with a virtual tiled floor in a checkerboard arrangement, which dynamically responds to the patient's own movement, much like a real floor, fixed in space. Intervention 2: Sham control group: received virtual reality balance exercises with tDCS off. This group receives only virtual reality treatment and the silent tDCS device is used for them. Intervention 3: Control group: Receive only virtual reality balance exercises.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals

When:
The access period starts 6 months after the results are published

To whom:
The data of this study will be available only to researchers working in academic and scientific institutions

Conditions:
The data of this study will be available for meta-analysis

Where to obtain:
Zahra Ahmadizadeh, Mashahir Square, Quds Boulevard, Neuromuscular Rehabilitation Research Center Phone: 00982333654180 Postal Code: 3513138111
ahmadizade.z@gmail.com

How to obtain:
In order to request the data of this study, it is necessary to send an official written request by e-mail and clearly explain the reason for the request.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Ahmadizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Damghan Road - Semnan Medical Sciences Campus - Faculty of Rehabilitation</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513138111</zip>
        <telephone>+98 23 3365 4180</telephone>
        <email>ahmadizade.z@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Ahmadizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semnan-Kilometer 5 Damghan Road-Semnan Medical Sciences school of Rehabilitation</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513138111</zip>
        <telephone>+98 23 3365 4190</telephone>
        <email>ahmadizade.z@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having MS as diagnosed by a neurologist
No history of falling in the last month according to the reference or family report
No addiction according to the client's, family or doctor's report
Not having obvious orthopedic, rheumatology, or internal problems that the person complains about (such as back pain, hallux valgus, flat feet, foot ulcers) according to the client's report, the family or the client's doctor, if you cause problems in the implementation of the tests
People with mild to moderate disability EDSS=1-5
Age range 18-60 years
having cognitive impairment (getting a score higher than 21 in the MMSE test)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Corticosteroid use up to 28 days before evaluation based on medical records and patient statements
Having mental problems (according to the patient's file)
Having a history of attacks and relapses in the last 2 months (according to the patient's file)
Having a history of other neurological diseases (according to the patient's file)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Multiple sclerosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: receiving virtual reality balance exercises with bright tDCS. To use tDCS, a direct stimulation current will be used by a pair of electrodes (cathode and anode). The current is controlled by an ammeter. Stimulation electrodes are 7x5 cm in size. When using TDCS, a current of 2 mA is applied to the cerebellum for a maximum of 20 minutes. Virtual reality device Visual cues are created by a virtual reality device. A closed loop device is installed on the head. , provides the patient with a virtual tiled floor in a checkerboard arrangement, which dynamically responds to the patient's own movement, much like a real floor, fixed in space.</i_keyword>
      <i_keyword>Sham control group: received virtual reality balance exercises with tDCS off. This group receives only virtual reality treatment and the silent tDCS device is used for them</i_keyword>
      <i_keyword>Control group: Receive only virtual reality balance exercises</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance. Timepoint: before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Biodex.</prim_outcome>
      <prim_outcome>Fear of falling. Timepoint: before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Fear of falling questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Fatigue. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Fatigue Severity Scale questionnaire.</sec_outcome>
      <sec_outcome>Activity of daily living. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Lawton questionnaire.</sec_outcome>
      <sec_outcome>Postural control. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Force Plate.</sec_outcome>
      <sec_outcome>Functional mobility. Timepoint: Before the start of the intervention, after the tenth session of the intervention, and 6 weeks after the end of the intervention. Method of measurement: Time Up &amp; Go test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-30</approval_date>
        <contact_name>Research Ethics Committees of Semnan University Of Medical Sciences and Health Services</contact_name>
        <contact_address>5 km Damghan Road, school of Rehabilitation Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
